Potent Preclinical Efficacy of DuoHexaBody-CD37 in B-Cell Malignancies

• Hilma J. van der Horst,
• Simone C. Oostindie,
• Saskia. A. G. M. Cillessen,
• Anne T. Gelderloos,
• Marije B. Overdijk,
• Inger. S. Nijhof,
• Sonja Zweegman,
• Martine E. D. Chamuleau,
• Esther C. W. Breij,
• Tuna Mutis

Affiliations

Hilma J. van der Horst

1 Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands

Simone C. Oostindie

2 Genmab, Utrecht, the Netherlands

Saskia. A. G. M. Cillessen

4 Department of Clinical Pathology, Amsterdam UMC, Amsterdam, the Netherlands.

Anne T. Gelderloos

1 Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands

Marije B. Overdijk

2 Genmab, Utrecht, the Netherlands

Inger. S. Nijhof

1 Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands

Sonja Zweegman

1 Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands

Martine E. D. Chamuleau

1 Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands

Esther C. W. Breij

2 Genmab, Utrecht, the Netherlands

Tuna Mutis

1 Department of Hematology, Cancer Center Amsterdam, Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands